A network approach reveals roles for cancer stem cells in cancer promotion
We talked to team PROMINENT members Professor Allan Balmain and Dr Mark Taylor from the University of California San Francisco about their latest paper ‘Stem-cell states converge in multi-stage cutaneous squamous cell carcinoma development…
We talked to team PROMINENT members Professor Allan Balmain and Dr Mark Taylor from the University of California San Francisco about their latest paper ‘Stem-cell states converge in multi-stage cutaneous squamous cell…
In a landmark paper published today (1 May, 2024) by the Mutographs team in Nature, they identify new mutational signatures at play in the development of clear cell renal cell carcinoma, of unknown origin, which…
Today we’re excited to announce the five new global teams that have been selected to each receive up to $25m in Cancer Grand Challenges funding over five years to take on four of cancer’s toughest challenges. In March…
As we look towards announcing our new teams on 6 March, we reflect with former members of the Cancer Grand Challenges Advocacy Panel on the role the panel plays in ensuring that the voice of people affected by cancer is…
Last month we held our annual Future Leaders Conference in Lisbon. As well as being a time for early career researchers from across our funded teams to come together, network and share their scientific findings, this…
New findings from the Cancer Grand Challenges PRECISION team this Breast Cancer Awareness Month show that breast cancer development from DCIS is a rare event and emphasise the urgent need for accurate prognostic markers…
Today we’re announcing a major new €10m (£8.6m) partnership between Cancer Research UK and France’s Institut National Du Cancer (INCa) to help fund world-class researchers to take on cancer’s toughest challenges through…
Today, we are excited to reveal the 12 shortlisted teams who are in with a chance of securing up to $25m in Cancer Grand Challenges funding to make radical progress against some of cancer’s toughest challenges. In…
New research from the Cancer Grand Challenges Rosetta team shows that metabolic profiling using a variety of mass spectrometry techniques can be used to stratify tissues according to their underlying mutations in…